Literature DB >> 8573382

Regional distribution of lesions in the central nervous system of cats infected with feline immunodeficiency virus.

F Abramo1, S Bo, M G Canese, A Poli.   

Abstract

Neuropathological examination of the central nervous system of 13 naturally and 13 experimentally feline immunodeficiency virus (FIV)-infected cats revealed diffuse gliosis of gray and white matter and vacuolar myelinopathy in a large proportion of infected animals, sometimes associated with lymphocytic meningitis. Multinucleated giant cell formation, the hallmark of multifocal giant cell encephalitis in HIV infection, was never observed. Morphometric analysis confirmed a marked increase of GFAP reactivity in infected cats. Gliosis was mainly present in cortical structures of frontal, parietal, and occipital lobes. Only one naturally infected animal evidenced clinical symptoms of neurological damage. This study confirms that FIV provides an interesting model for studying HIV-induced cortical and subcortical brain pathology believed to be the cause of the neurological manifestations frequently observed in AIDS patients.

Entities:  

Mesh:

Year:  1995        PMID: 8573382     DOI: 10.1089/aid.1995.11.1247

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers.

Authors:  Gavin Ryan; Terence Grimes; Brenda Brankin; Mohamad J E M F Mabruk; Margaret J Hosie; Oswald Jarrett; John J Callanan
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

Review 2.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

3.  High resolution MRI anatomy of the cat brain at 3 Tesla.

Authors:  Heather L Gray-Edwards; Nouha Salibi; Eleanor M Josephson; Judith A Hudson; Nancy R Cox; Ashley N Randle; Victoria J McCurdy; Allison M Bradbury; Diane U Wilson; Ronald J Beyers; Thomas S Denney; Douglas R Martin
Journal:  J Neurosci Methods       Date:  2014-02-10       Impact factor: 2.390

Review 4.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

5.  Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.

Authors:  C Power; R Buist; J B Johnston; M R Del Bigio; W Ni; M R Dawood; J Peeling
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 6.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

Review 7.  Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Authors:  Rick B Meeker
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-28       Impact factor: 4.147

8.  Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Authors:  Paweł M Bęczkowski; Annette Litster; Tsang Long Lin; Dominic J Mellor; Brian J Willett; Margaret J Hosie
Journal:  Vet Microbiol       Date:  2015-01-03       Impact factor: 3.293

9.  Pathology in Captive Wild Felids at German Zoological Gardens.

Authors:  Johannes Junginger; Florian Hansmann; Vanessa Herder; Annika Lehmbecker; Martin Peters; Martin Beyerbach; Peter Wohlsein; Wolfgang Baumgärtner
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 10.  Clinical aspects of feline retroviruses: a review.

Authors:  Katrin Hartmann
Journal:  Viruses       Date:  2012-10-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.